Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Immunomodulator Therapeutics Market, Global, 2024–2030
... and regulate pathological immune responses, either by inhibiting or suppressing them. It categorizes the market by modality and key indications, providing a 6-year revenue forecast for global immunomodulator prescription drugs, alongside an analysis of key ... Read More
-
2025 Global Forecast for Localized Autoimmune Disease Diagnostics Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the blood and blood-forming ... Read More
-
Liver Disease Treatment Market Report by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033
... 2025-2033. The growing elderly population worldwide, which is prone to several chronic illnesses, including liver disease, is stimulating the market. The liver is a vital organ of the human body that performs significant functions, such ... Read More
-
Aplastic Anemia - Global Clinical Trials Review, 2025
... line data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
2025 Global: Hydroxychloroquine Sulfate Tablets Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
... The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by pharmaceutical companies are propelling the market growth. In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Veterinary Autoimmune Disease Therapeutics Global Market Report 2025
... disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Intravenous Immunoglobulin (IVIg)
... at a CAGR of 8.5% over the analysis period 2024-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Autoimmune Disease Therapeutics
... at a CAGR of 3.8% over the analysis period 2024-2030. Anti-inflammatory, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$183.0 Billion by the end of the ... Read More
-
Immunotherapy Drugs
... CAGR of 9.6% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of the analysis ... Read More
-
Lupus Therapeutics
... CAGR of 8.7% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Systemic Lupus Erythematosus (Sle) Drugs
... Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$68.0 Million While China is Forecast to Grow at 6.1% CAGR The Systemic Lupus Erythematosus ... Read More
-
Thyroid Gland Disorder Treatment
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hypothyroidism, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.6 Billion by the end ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Guillain-Barré Syndrome (GBS): ... Read More
-
Digital Biomarkers Market by Type of Product
... 18.48% during the forecast period, till 2035. The market opportunity for cell and gene therapy supply chain software has been distributed across the following segments: Type of Product Software / Applications Wearables Sensors Gaming Solutions ... Read More
-
Bispecific Antibodies Market by Therapeutic Area
... 9.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Therapeutic Area Autoimmune Disorders Genetic Disorders Hematological Malignancies Ophthalmic Disorders Skin Cancers Solid Tumors Mechanism ... Read More
-
Global Celiac Diseases Drugs Market 2025-2029
... diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
In-vitro Diagnostics Enzymes Market Size, Share, and Outlook, 2025 Report- By Type (Proteases, Polymerase & Transcriptase, Ribonuclease, Others), By Disease , Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Others), By Technology (Histology Assays, Molecular Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on In-vitro Diagnostics Enzymes segments across 22 countries ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Share, and Outlook, 2025 Report- By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Biopharmaceuticals Contract Manufacturing segments across 22 countries ... Read More
-
Pharmaceutical Market Size, Share, and Outlook, 2025 Report- By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), 2021-2032
... potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Pharmaceutical segments across 22 countries from 2021 to 2032. Key segments in the ... Read More
-
Autoimmune Drugs Markets in China
... which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply ... Read More
-
Autoimmune Drugs Companies in China
... consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest ... Read More
-
Autoimmune Drugs Industry Forecasts - China Focus
... China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for ... Read More
Research Assistance
